Computer-aided design and synthesis of 3-carbonyl-5-phenyl-1H-pyrazole as highly selective and potent BRAFV600E and CRAF inhibitor
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Jinwoong | - |
dc.contributor.author | Choi, Byeongha | - |
dc.contributor.author | Im, Daseul | - |
dc.contributor.author | Jung, Hoyong | - |
dc.contributor.author | Moon, Hyungwoo | - |
dc.contributor.author | Aman, Waqar | - |
dc.contributor.author | Hah, Jung-Mi | - |
dc.date.accessioned | 2021-06-22T10:26:29Z | - |
dc.date.available | 2021-06-22T10:26:29Z | - |
dc.date.created | 2021-01-21 | - |
dc.date.issued | 2019-01 | - |
dc.identifier.issn | 1475-6366 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/3596 | - |
dc.description.abstract | BRAF belongs to the upstream portion of the MAPK pathway, which is involved in cell proliferation and survival. When mutations occur in BRAF, downstream MEK and ERK are phosphorylated irrespective of RAS, resulting in melanoma-like cancer. Over the years, small molecules targeting BRAFV600E have been discovered to be very effective melanoma drugs, but they are known to cause the BRAF paradox. Recently, it was shown that this paradox is caused by the heterodimer phenomenon of BRAF/CRAF. Here, we suggest one method by which paradoxical activation can be avoided by selectively inhibiting BRAFV600E and CRAF but not wild-type BRAF. From previous report of N-(3-(3-alkyl-1H-pyrazol-5-yl) phenyl) aryl amide as a selective inhibitor of BRAFV600E and CRAF, we present compounds that offer enhanced selectivity and efficacy with the aid of molecular modelling. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | TAYLOR & FRANCIS LTD | - |
dc.title | Computer-aided design and synthesis of 3-carbonyl-5-phenyl-1H-pyrazole as highly selective and potent BRAFV600E and CRAF inhibitor | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Hah, Jung-Mi | - |
dc.identifier.doi | 10.1080/14756366.2019.1599366 | - |
dc.identifier.scopusid | 2-s2.0-85069534336 | - |
dc.identifier.wosid | 000475613100001 | - |
dc.identifier.bibliographicCitation | JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, v.34, no.1, pp.1314 - 1320 | - |
dc.relation.isPartOf | JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY | - |
dc.citation.title | JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY | - |
dc.citation.volume | 34 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 1314 | - |
dc.citation.endPage | 1320 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.subject.keywordPlus | RAF | - |
dc.subject.keywordPlus | PATHWAY | - |
dc.subject.keywordAuthor | Melanoma | - |
dc.subject.keywordAuthor | BRAFV600E | - |
dc.subject.keywordAuthor | BRAFWT | - |
dc.subject.keywordAuthor | CRAF | - |
dc.subject.keywordAuthor | selectivity | - |
dc.identifier.url | https://www.tandfonline.com/doi/full/10.1080/14756366.2019.1599366 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.